跳至主要内容
临床试验/NCT01346774
NCT01346774已完成2 期

Phase II Efficacy of Cranberry Powder in Preventing Catheter-associated Urinary Tract Infection Post Elective Gynecological Surgery

Betsy Foxman1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2011年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
Participants With Clinically-diagnosed and Treated UTI's.

研究概览

简要总结

Approximately 10-27% of patients undergoing gynecologic surgeries develop a catheter associated urinary tract infection (CAUTI) in the post operatory period, as bladder catheterization is a common practice in gynecologic surgery. Cranberry products provide alternative means for preventing CAUTI and could result in decreased use of antimicrobials. In this pilot study we will enroll 200 women post gynecologic surgery and randomize them to take either cranberry powder capsules or placebo powder capsules. The low risk of harm associated with using cranberry to reduce UTI coupled with its potential benefit makes it a desirable intervention for the prevention of CAUTI. The conduct/ results of this pilot /feasibility study will prepare us for the conduct of a large scale clinical trial.

详细描述

Cranberry products prevent bacteria that cause UTI, especially Escherichia coli, from adhering to bladder cell wall thus preventing infection. Adherence of type 1 pili is inhibited by the fructose and of p pili by the proanthocyanidins present in cranberry.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Presenting at the gynecology clinic for a pre-operatory visit
  • Ability to give informed consent
  • Willing to take cranberry capsules for up to 6 weeks
  • 18 of age or older

排除标准

  • History of nephrolithiasis
  • History of allergy to cranberry
  • Patient on anticoagulant medicine to be re-started during the 4-6 weeks after surgery
  • Less than 18 years old

研究组 & 干预措施

Cranberry powder capsules

Experimental

TheraCran® cranberry: based upon proanthocyanidin content, the four cranberry capsules are equivalent to two 8-ounce servings of cranberry juice.

Participants were directed to take two capsules by mouth twice each day (once in the morning and once in the evening) starting at time of discharge for 4-6 weeks, or until their return for their post-operative doctor's visit. Participants were instructed to drink an 8 oz glass of water while taking the capsule with or without food.

干预措施: Cranberry powder capsules (Drug)

Placebo capsules

Placebo Comparator

Placebo: participants were directed to take two capsules by mouth twice each day (once in the morning and once in the evening) starting at time of discharge for 4-6 weeks, or until their return for their post-operative doctor's visit. Participants were instructed to drink an 8 oz glass of water while taking the capsule with or without food.

干预措施: Placebo powder capsules (Drug)

结局指标

主要结局

Participants With Clinically-diagnosed and Treated UTI's.

时间窗: From surgery to post-op visit, approximately 6 weeks post surgery

The primary endpoint was the number of participants who were clinically-diagnosed and treated for UTI whether or not results from a urine culture were available. All UTI's were confirmed via medical records.

次要结局

未报告次要终点

研究者

发起方
Betsy Foxman
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Betsy Foxman

Hunein F & Hilda Maassab Professor of Epidemiology

University of Michigan

研究点 (1)

Loading locations...

相似试验